Table of Contents
From the Editor
- Double the reasons for giving the flu vaccine in 2020
Limiting the impact of other diseases, possibly including COVID-19.
The Clinical Picture
1-Minute consult
- Does my healthy 65-year-old patient still need the 13-valent pneumococcal conjugate vaccine (PCV13)?
The short answer is no—but it is not that simple.
COVID-19 Curbside Consults
- Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19
Consider the presentation and trajectory of illness.
- Convalescent plasma for COVID-19: Promising, not proven
The evidence is suggestive but weak. Trials are ongoing.
Review
- Using and interpreting electrodiagnostic tests
They supplement a neurologic examination in a variety of neuromuscular conditions.
- Contrast media in patients with kidney disease: An update
The risk of acute kidney injury is real, but lower than initially thought.
- The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults
Patients can have variable responses to vaccines, depending on the vaccine and the DMARD.
Commentary
Measures to combat COVID-19 can minimize the impact of flu, and vice versa.